Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Vaccines

Free Subscription 08.12.2025 1 BMJ 1 J Infect 1 J Infect Dis 1 JAMA 3 N Engl J Med 7 Pediatrics 3 PLoS One 24 Vaccine 2 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. LOGAN M
   FDA claims 10 child deaths caused by covid-19 vaccine, vows to tighten vaccine approvals.
   BMJ. 2025;391:r2546.
   PubMed        
   
   

   
   J Infect

2. KELLY E, Greenland M, de Whalley P, Macaulay GC, et al
   Reactogenicity and Immunogenicity following Heterologous and Homologous Third Dose COVID-19 vaccination in UK Adolescents (Com-COV3): A Randomised Controlled Non-Inferiority Trial.
   J Infect. 2025 Dec 1:106663. doi: 10.1016/j.jinf.2025.106663.
   PubMed         Abstract available
   
   

   
   J Infect Dis

3. SUMNER KM, Katz M, Hirsch A, Peretz A, et al
   Improved immune response against influenza A viruses with receipt of a recombinant influenza vaccine in healthcare personnel with prior low antibody response to egg-based influenza vaccines, Israel, 2019-20.
   J Infect Dis. 2025 Dec 3:jiaf605. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   JAMA

4. ABERS MS, Ulrich AK, Walensky RP
   Universal Hepatitis B Vaccination at Birth-Risks of Revising the Recommendation.
   JAMA. 2025 Dec 3. doi: 10.1001/jama.2025.24996.
   PubMed        
   
   

   
   N Engl J Med

5. CALIFF RM, von Eschenbach AC, Friedman MA, Giroir BP, et al
   A Threat to Evidence-Based Vaccine Policy and Public Health Security at the FDA.
   N Engl J Med. 2025 Dec 3. doi: 10.1056/NEJMp2517497.
   PubMed        
   
   
6. KREIMER AR, Porras C, Liu D, Hildesheim A, et al
   Noninferiority of One HPV Vaccine Dose to Two Doses.
   N Engl J Med. 2025 Dec 3. doi: 10.1056/NEJMoa2506765.
   PubMed         Abstract available
   
   
7. BARNABAS RV
   Evidence to Action - Single-Dose HPV Vaccination and Cervical HPV Infection.
   N Engl J Med. 2025 Dec 3. doi: 10.1056/NEJMe2515387.
   PubMed        
   
   

   
   Pediatrics

8. 
   Recommendations for Prevention and Control of Influenza in Children, 2025-2026: Policy Statement.
   Pediatrics. 2025 Jul 28. doi: 10.1542/peds.2025-073620.
   PubMed         Abstract available
   
   
9. 
   Recommendations for Prevention and Control of Influenza in Children, 2025-2026: Technical Report.
   Pediatrics. 2025 Jul 28. doi: 10.1542/peds.2025-073622.
   PubMed         Abstract available
   
   
10. MEHRA A, Anvari S
    Prior Vaccination Prevents Overactivation of Innate Immune Responses During COVID-19 Breakthrough Infection.
    Pediatrics. 2025;156.
    PubMed        
    
    
11. MASON AE, Stukus D
    Vaccine Coverage at 36 Months and 7 Years by Parental Birth Country, Washington State.
    Pediatrics. 2025;156.
    PubMed        
    
    
12. LA MANTIA A, Stukus D
    Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine.
    Pediatrics. 2025;156.
    PubMed        
    
    
13. KELSO JM
    Safety of LAIV Vaccination in Asthma or Wheeze: A Systematic Review and GRADE Assessment.
    Pediatrics. 2025;156.
    PubMed        
    
    
14. NIRENBERG E, Maldonado YA, Hoffman SA
    The Role and Safety of Aluminum Adjuvants in Childhood Vaccines.
    Pediatrics. 2025 Dec 3. doi: 10.1542/peds.2025-074874.
    PubMed         Abstract available
    
    

    
    PLoS One

15. LI M, Liang L, Chen X, Zhu Z, et al
    Bridging knowledge gaps: An observational study on HPV awareness and misconceptions among young adults in China.
    PLoS One. 2025;20:e0337518.
    PubMed         Abstract available
    
    
16. EL-AKKAD SE, Shao S, Tran KC, Naik H, et al
    Association between COVID-19 vaccination, SARS-CoV-2 variants, and post COVID-19 condition: A cross-sectional study.
    PLoS One. 2025;20:e0336929.
    PubMed         Abstract available
    
    
17. LEET DE, Jin J, Craik CS, Kattah MG, et al
    Post-vaccination SARS-CoV-2 neutralizing antibodies in pregnant women receiving biologics for inflammatory bowel disease.
    PLoS One. 2025;20:e0321242.
    PubMed         Abstract available
    
    

    
    Vaccine

18. SEN BK, Ghosh RR, Rahman M, Ahmed I, et al
    Vaccines as a strategic approach to combat Vibrio parahaemolyticus and control of early mortality syndrome sin shrimp aquaculture: A comprehensive review.
    Vaccine. 2025;71:128049.
    PubMed         Abstract available
    
    
19. ABBAD A, Lerman B, Ehrenhaus J, Ojeda DS, et al
    Sustained superior humoral immune responses of mRNA vaccines compared to Sputnik V viral vector COVID-19 vaccines in naive and convalescent populations.
    Vaccine. 2025;70:128018.
    PubMed         Abstract available
    
    
20. GENSOROWSKY D, Surmann B, Meyer AC, Poshtiban A, et al
    Outpatient care intensity and influenza vaccination: evidence from Germany.
    Vaccine. 2025;70:128038.
    PubMed         Abstract available
    
    
21. KOU G, Cheng Y, Zhang G, Wang Y, et al
    A live-attenuated human-lamb rotavirus reassortant confers robust protective immunity in mice.
    Vaccine. 2025;68:127898.
    PubMed         Abstract available
    
    
22. SONG X, Peng Q, Zhang X, Zhao Y, et al
    Enhanced immunogenicity of swine coronavirus PEDV by engineering transcriptional regulatory sequences.
    Vaccine. 2025;68:127914.
    PubMed         Abstract available
    
    
23. SAHA S, van Binnendijk R, Ussher J, Ten Hulscher H, et al
    Limitations of serological screening for measles immunity in young health care workers in New Zealand.
    Vaccine. 2025;68:127931.
    PubMed         Abstract available
    
    
24. COUTO P, Campbell H, Li Y, Rondy M, et al
    Implications of respiratory syncytial virus seasonality for the timing of passive immunisation scenarios in Latin America and the caribbean - a cross-sectional modelling study.
    Vaccine. 2025;68:127934.
    PubMed         Abstract available
    
    
25. HUANG Y, Li T, Zhang Y, Wang H, et al
    Comparable protective efficacy of Brucella melitensis outer membrane vesicles via intramuscular, subcutaneous, and intranasal immunization routes in mice.
    Vaccine. 2025;68:127963.
    PubMed         Abstract available
    
    
26. TALESHI J, Paramo MV, Watts A, Chilvers M, et al
    Cost-effectiveness of infant and maternal RSV immunization strategies, in British Columbia, Canada.
    Vaccine. 2025;68:127936.
    PubMed         Abstract available
    
    
27. PICHE-RENAUD PP, Buchan CA, Burton C, Chapdelaine H, et al
    Revaccination of individuals with cardiac adverse events following COVID-19 vaccination: A Canadian Immunization Research Network study.
    Vaccine. 2025;70:128016.
    PubMed         Abstract available
    
    
28. BIAN H, Zhang S, Zhu Z, Cao Y, et al
    Preparation and evaluation of genetically engineered recombinant subunit vaccines containing serine metalloprotease, anchor M domain-containing protein, and pyolysin against Trueperella pyogenes infection in a mouse model.
    Vaccine. 2025;69:128009.
    PubMed         Abstract available
    
    
29. FREY SE, Baden LR, El Sahly HM, Davey RT, et al
    Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination.
    Vaccine. 2025;69:127959.
    PubMed         Abstract available
    
    
30. TEWARI T, Armah G, Cunliffe NA, Chisenga CC, et al
    Safety, immunogenicity, and relative efficacy of a parenteral trivalent rotavirus subunit vaccine candidate (TV P2-VP8) in healthy Ghanaian, Malawian, and Zambian infants.
    Vaccine. 2025;70:128019.
    PubMed         Abstract available
    
    
31. LADOMENOU F, Gorla E, Matalliotakis M, Serbis A, et al
    Determinants of human papillomavirus (HPV) vaccine uptake and health literacy regarding HPV infection and vaccine among undergraduate university students in Greece.
    Vaccine. 2025;70:128042.
    PubMed         Abstract available
    
    
32. DEV AS, Broos HC, Llabre MM, Saab PG, et al
    Examining the independent and interactive roles of intolerance of uncertainty in vaccination intent.
    Vaccine. 2025;70:128008.
    PubMed         Abstract available
    
    
33. KAWAZOE Y, Katsuta T, Tanaka T, Nakamura Y, et al
    Prevalence of HPV vaccine-associated symptoms in unvaccinated Japanese adolescents: A descriptive study from the VENUS study database.
    Vaccine. 2025;70:128020.
    PubMed         Abstract available
    
    
34. LE TOURNEAU N, Sharma A, Pry JM, Haambokoma M, et al
    Drivers of decision-making for future adult vaccines: a best-worst scaling among community members and health care workers in Zambia.
    Vaccine. 2025;70:128003.
    PubMed         Abstract available
    
    
35. ZHANG X, Xu T, Xian J, Liu J, et al
    Development of a recombinant fusion protein subunit vaccine comprising two truncated proteins effectively protects largemouth bass against infectious spleen and kidney necrosis virus infection.
    Vaccine. 2025;70:128007.
    PubMed         Abstract available
    
    
36. HAMMOUD M, Smith AKJ, Sachs O, Bavinton BR, et al
    Drivers, barriers, and implications of mpox vaccine uptake in Australia among gay, bisexual, and other men who have sex with men: results from a prospective observational mixed-methods study (2022-2024).
    Vaccine. 2025;70:128041.
    PubMed         Abstract available
    
    
37. KIM SH, Kang MG, Jang JG, Kim Y, et al
    Severe COVID-19, vaccination, and mortality among individuals with asthma: A Nationwide population-based cohort study.
    Vaccine. 2025;70:128017.
    PubMed         Abstract available
    
    
38. RHYNE PW, Sunshine J, Hogrefe W, Roscia G, et al
    Corrigendum to "Development and qualification of a multiplexed immunoassay to assess the immunogenicity of Shigella vaccines" [Vaccine 68 (2025) 127896].
    Vaccine. 2025;70:128014.
    PubMed        
    
    
39. MIKAS J, Zibolenova J, Litvova S, Baska T, et al
    Seroprevalence of measles, mumps and rubella specific antibodies in the population of Slovakia: One vaccine, three different patterns.
    Vaccine. 2025;70:128039.
    PubMed         Abstract available
    
    
40. MESSINA NL, Pittet LF, Forbes EK, Francis KL, et al
    Neonatal BCG vaccination to prevent respiratory infections in the first 5 years of life: results from the MIS BAIR randomised controlled trial.
    Vaccine. 2025;69:127958.
    PubMed         Abstract available
    
    
41. PEI C, Zeng D, He C, Sun W, et al
    A national survey on HPV vaccination status among 42,800 female physicians and nurses in China, 2021.
    Vaccine. 2025;70:128025.
    PubMed         Abstract available
    
    

    
    Virology

42. LONG J, Liu K, Chen Y, Wang X, et al
    Attenuation of a contemporary Chinese PRRSV-1 strain via serial cell passage and evaluation of its protective efficacy as a modified live virus vaccine candidate.
    Virology. 2025;615:110746.
    PubMed         Abstract available
    
    
43. LI J, Yang Q, Yang Z, Huyan Y, et al
    Structural and immunogenic characteristics of goose parvovirus virus-like particles.
    Virology. 2026;614:110727.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.